Alcon Inc. (LON:0A0D)
London · Delayed Price · Currency is GBP · Price in CHF 62.48
-1.17 (-1.83%)
At close: Sep 11, 2025
Alcon Market Cap
Alcon has a market cap or net worth of 28.68 billion as of September 12, 2025. Its market cap has decreased by -20.17% in one year.
Market Cap
28.68B
Enterprise Value
31.53B
Revenue
7.32B
Ranking
n/a
PE Ratio
36.62
Stock Price
62.48
Market Cap Chart
Since April 9, 2019, Alcon's market cap has increased from 21.72B to 28.68B, an increase of 32.04%. That is a compound annual growth rate of 4.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 28.68B | -14.41% |
| Dec 30, 2024 | 33.51B | 11.02% |
| Dec 29, 2023 | 30.18B | 8.25% |
| Dec 30, 2022 | 27.88B | -13.06% |
| Dec 30, 2021 | 32.07B | 31.94% |
| Dec 30, 2020 | 24.31B | 14.73% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 185.40B |
| GSK plc | 60.53B |
| Haleon | 32.39B |
| Smith & Nephew | 12.20B |
| ConvaTec Group | 4.79B |
| Hikma Pharmaceuticals | 3.61B |
| HUTCHMED (China) | 2.05B |
| Genus | 1.72B |